Saudi Arabia Viscosupplementation Market Size & Outlook
Saudi Arabia viscosupplementation market, 2018-2030 (US$M)
Related Markets
Saudi Arabia viscosupplementation market highlights
- The Saudi Arabia viscosupplementation market generated a revenue of USD 2.6 million in 2023 and is expected to reach USD 5.2 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 10.1% from 2024 to 2030.
- In terms of segment, single injection was the largest revenue generating product in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2023 | USD 2.6 million |
| Market revenue in 2030 | USD 5.2 million |
| Growth rate | 10.1% (CAGR from 2023 to 2030) |
| Largest segment | Single injection |
| Fastest growing segment | Single Injection |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.1% of the global viscosupplementation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa viscosupplementation market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 5.2 million by 2030.
Single injection was the largest segment with a revenue share of 46.15% in 2023. Horizon Databook has segmented the Saudi Arabia viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
In the Middle East, more than one million people suffer from OA in Iraq, Yemen, Saudi Arabia, and Syria. Approximately 85% of individuals over the age of 75 years of age experience some symptoms of osteoarthritis 40% of individuals with the disorder experience significant difficulties with daily activities to the point of interfering with work-related or social roles.
In the study conducted at Arar, KSA in the year 2018 on the geriatric population, the overall prevalence rate of osteoarthritis of the knee joint was 24.5%; male to female ratio was found out to be 48.3 to 51.7.
In another study, it was estimated the prevalence of knee OA was found to be around 53% and 61% in male and females respectively. In addition, they found that the prevalence of radiographic knee OA increases with age.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia viscosupplementation market size, by product, 2018-2030 (US$M)
Saudi Arabia Viscosupplementation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
